| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/16/2006 | EP1689354A2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1385578B1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0917873B1 Eyedrops |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819846A Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817351A Production of variolaria amra medicinal extract and its medicinal preparation |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/16/2006 | CN1269484C Serotonergic 5HT2 agonists for treating glaucoma |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/10/2006 | WO2006083841A2 Therapeutic esters |
| 08/10/2006 | WO2006068795A3 Use of inhibitors of formyl peptide receptors for reducing intraocular pressure |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/10/2006 | US20060178368 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060177524 Ocular irrigating solution |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688144A1 Ophthalmic compositions containing quinolone-antibiotics |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1687030A2 Combination of a dpp iv inhibitor and an anti-obesity or appetite regulating agent |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1227859B1 Neurophilin ligands for treating ocular conditions |
| 08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
| 08/09/2006 | EP1104302A4 Prophylactic treatments of neovascularisation in macular degeneration |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816530A Opthalmic compositions for treating ocular hypertension |
| 08/09/2006 | CN1816281A Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1814278A Iirudo-seu-whitmania essence inhalant and preparing method |
| 08/09/2006 | CN1814275A Nano compound eye-drop containing piptide-like medicine and preparing method |
| 08/09/2006 | CN1814071A Zhangyanming capsule and preparing process |
| 08/09/2006 | CN1814044A Capsule or tablet for relieving vision fatigue and preparing method |
| 08/09/2006 | CN1813955A Medicine for treating tympanitis and otitis externa, and preparing method |
| 08/09/2006 | CN1813934A Formulation formula for treating acute-chronic purulent tympanitis |
| 08/09/2006 | CN1813920A Medicinal composition with synergistic effect |
| 08/09/2006 | CN1813917A Medicine for treating acute secretory tympanitis and its preparing method |
| 08/09/2006 | CN1813843A Eye medicinal composition for treating acute-chronic conjunctivitis and its preparing method |
| 08/09/2006 | CN1813829A Injection holly root lyophilized powder for treating cardio-cerebral vascular disease and its preparing method |
| 08/09/2006 | CN1813777A Medicine for treating diabetes retina disease |
| 08/09/2006 | CN1813758A Levofloxacin hydrochloride micro-pill capsule and its preparing method |
| 08/09/2006 | CN1813756A Ganciclouir dispersible tablet and its preparing method |
| 08/09/2006 | CN1813752A Fluorouracial nano particle formulation and its preparing method |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/09/2006 | CN1268354C Traditional Chinese medicine preparation for treating myopia and method for preparing the same |
| 08/09/2006 | CN1268353C Traditional Chinese medicine preparation for treating amblyopia and method for preparing the same |
| 08/09/2006 | CN1268344C Puerarin gelation for eye use and preparing. method |
| 08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087237 Ocular solutions |
| 08/08/2006 | CA2431368C Intraocular irrigating solution having improved flow characteristics |